Use of CMV transcripts for monitoring of CMV infections in transplant recipients

International Journal of Antimicrobial Agents

Volumn 16, Issue 4, 2000, Pages 455-460

  Gerna, Giuseppe ^a   Baldanti, Fausto ^a   Middeldorp, Jaap ^b   Lilleri, Daniele ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Organon Teknika   (Netherlands)

Author keywords

HCMV; Immediate early and late transcripts; Transplant recipients

Indexed keywords

ANTIGEN PP67; BLOOD GROUP ANTIGEN; FOSCARNET; GANCICLOVIR; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; GRAFT INFECTION; HEART TRANSPLANTATION; HUMAN; IMMEDIATE EARLY GENE; INFECTION RISK; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIREMIA; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; RETROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS; TRANSPLANTATION;

EID: 0033664513     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00279-X     Document Type: Article

References (26)

1. Detection of human cytomegalovirus immediate-early antigen in leukocytes as a marker of viremia in immunocompromised patients
2. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
3. Quantitation of cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescent-based detection system
4. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
5. Quantitation of human cytomegalovirus DNA using the polymerase chain reaction
6. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis
7. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients
8. Quantitation of human cytomegalovirus (HCMV) in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases
9. Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection
10. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients
11. Human cytomegalovirus (HCMV) infection in pediatric patients given allogeneic bone marrow transplantation: Role of early antiviral treatment for HCMV antigenemia on patients' outcome
12. Preemptive therapy in immunocompromised hosts
13. Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection
14. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia and leuko DNAemia
15. Human cytomegalovirus (HCMV) late mRNA detection in peripheral blood of AIDS patients: Diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection
16. Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse-transcription-PCR and blood and urine culture
17. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients
18. A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients
19. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification
20. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification
21. Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification
22. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia
23. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes
24. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins
25. Rapid and simple method for purification of nucleic acids
26. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients